mint Analytics: Real-time data visualization and analysis in clinical trials with imaging endpoints

We talked to PD Dr. Wolfgang G. Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig Maximilians University Hospital Munich, about his experience with mint Analytics, an extensive add-on of the leading radiological platform mint Lesion™.

Next to the data visualization of multiple trials, PD Dr. Kunz and his team use mint Analytics for quality control of trial site reads and for sharing the current status of trial results with oncological PIs, which provides them with an estimate of what responses can be clinically expected. PD Dr. Kunz also provides an insight into how mint Analytics has the ability to open up new avenues of single and multicentric research projects and how this can benefit other radiologists, oncologists, imaging CROs as well as sponsors.

Related Resources

Related Resources

Assessment time halved: Importance of a good tumor response assessment tool in clinical site reads

The Clinical Research Imaging Core (CRIC) of the University of Wisconsin Carbone Cancer Center (UWCCC) recently published a poster at the AACI CRI…

Study - free text reporting vs. mint Lesion in clinical routine

Free text reporting in the tumor response assessment of radiologic imaging data is common in clinical routine, whereas in clinical trials standardized…

6 years of Mint at University Hospital Basel - Interview with PD Dr. Tobias Heye

Since the end of 2011, mint Lesion™ has been in use at the University Hospital in Basel, Switzerland, – initially merely as a tool for clinical…